Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-center Observational Study for the Clinical Validation of the Next Generation Test for Blood-based Screening of Colorectal Cancer

NCT05551052 is registered in ClinicalTrials.gov with New Day Diagnostics as lead sponsor.

NCT NCT05551052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05551052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-center Observational Study for the Clinical Validation of the Next Generation Test for Blood-based Screening of Colorectal Cancer
Lead sponsor
New Day Diagnostics
Phase
Observational
Overall status
Active, not recruiting
Start date
September 8, 2022
Completion date
December 31, 2027
Enrollment
196 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adenoma, adenomas colon, colon cancer, colon disease, colon lesion, colon neoplasm, colon polyp, colonic diseases, functional, colorectal cancer, gastrointestinal neoplasms, intestinal disease, intestinal neoplasms, polyps, rectal cancer, rectal diseases, rectal polyp